StockWatch
·

BAL PHARMA LTD.

BSE: 524824

Shareholding Trends

Ownership split

PromoterPublicOthers
0%19%38%57%Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Institutional detail

FII / FPIDII
0%0%0%0%Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Q1 FY27

Corporate Events

Board MeetingBALPHARMA
2026
11Nov

Board Meeting

The meeting of the Board of Directors of Bal Pharma Limited …

BSE Filing ↗
Board MeetingBALPHARMA
2026
24Sep

Board Meeting

The Board of Directors approved and fixed the date and time …

BSE Filing ↗
DividendBALPHARMA
2026
17Sep

₹1.2 / share

BSE Filing ↗
Board MeetingBALPHARMA
2026
12Aug

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingBALPHARMA
2026
27May

Board Meeting

The board meeting is scheduled to consider and approve the a…

BSE Filing ↗
Board MeetingBALPHARMA
2025
13Feb

Board Meeting

Regular agenda items

BSE Filing ↗
Board MeetingBALPHARMA
2024
14Nov

Board Meeting

To take on record and approve the Un-audited standalone and …

BSE Filing ↗
Board MeetingBALPHARMA
2024
9Sep

Board Meeting

Allotment Of Equity Shares To The Employees Of The Company U…

BSE Filing ↗
Board MeetingBALPHARMA
2024
28May

Board Meeting

Approval of Audited Standalone and Consolidated financial re…

BSE Filing ↗
Board MeetingBALPHARMA
2024
12Feb

Board Meeting

Approval of Un-audited Standalone and Consolidated financial…

BSE Filing ↗
Board MeetingBALPHARMA
2023
8Nov

Board Meeting

Approval of Un-audited Standalone and Consolidated financial…

BSE Filing ↗
DividendBALPHARMA
2023
25Sep

₹0.01 / share

BSE Filing ↗
Board MeetingBALPHARMA
2023
11Aug

Board Meeting

Consideration and approval of Un-Audited Standalone and Cons…

BSE Filing ↗